A decrease in TBA leads to upregulation of CYP2E1, which inhibits HCC cell proliferation, blocks cholic acid (CA)-activated autophagy, and reduces protein kinase B (AKT) phosphorylation through the AKT/mTOR signaling pathway [67]. Here, AKT1 is linked to hepatocellular carcinoma.